Novan, Inc. (NOVN) Social Stream
Novan Inc (NOVN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Novan Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $70 | $16 | $36 | $4.08 | 782.35% |
| 4 | $72 | $16 | $36.4 | $4.08 | 792.16% |
NOVN reports an average of 468.37% for its upside potential over the past 18 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 4 | 70.0 | 16.0 | 36.0 | 5.52 | 552.17% |
| 2021-11-11 | 4 | 70.0 | 16.0 | 36.0 | 6.56 | 448.78% |
| 2021-11-04 | 4 | 72.0 | 16.0 | 36.4 | 7.22 | 404.16% |
| 2020-08-17 | 2 | 4.5 | 1.5 | 3.0 | NA | NA% |
| 2020-05-22 | 1 | 1.5 | 1.5 | 1.5 | NA | NA% |
NOVN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
NOVN's average broker recommendation rating improved by 1 over the prior 31 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, Novan Inc's upside potential (average analyst target price relative to current price) is higher than 198.23% of them.
- In terms of how Novan Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -97.63% of that group.
- In terms of how Novan Inc fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 151.07% of that group.
- In terms of how Novan Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 50.98% of that group.
Stocks similar to Novan Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MNPR, CLRB and TRDA.
Is NOVN a Buy, Hold or Sell? See the POWR Ratings now!